Friedhelm Blobel

Friedhelm Blobel appears in our data through filings on Sciclone Pharmaceuticals Inc shares, published by SEC (Form 4). In total, 131 filings cover trades dated from 4 January 2016 to 13 October 2017.

No open-market purchase appears, only 56 sales worth €11.1M. Outside the open market, there are 8 share grants and 66 option exercises. 2017 to date brings no purchases and 39 sales.

The latest filing, published on 16 October 2017, reports an option exercise in Sciclone Pharmaceuticals Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.